Skip to main content Back to Top
Advertisement

1/6/2016

Boceprevir Capsules

Products Affected - Description

    • Victrelis oral capsule, Merck, 200 mg, 28 bottles 12 count, NDC 00085-0314-02

Reason for the Shortage

    • Merck Sharp & Dohme made a business decision to discontinue Victrelis capsules in the US by December 2015.
    • Merck Sharp & Dohme is the sole supplier of boceprevir capsules.

Estimated Resupply Dates

    • Merck Sharp & Dohme has discontinued Victrelis 200 mg capsules.

Updated

Updated January 6, 2016 by Jane Chandramouli, PharmD, Drug Information Specialist. Created January 20, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins